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Cancer survivors meet survivorship with uncertainty due to a lack of uniform information 
provided post cancer treatment. The implementation of survivorship care plans (SCP) has been 
recognized by key stakeholders as the solution to transitional uncertainties. 
In fact, to achieve accreditation by the Commission on Cancer (CoC) cancer centers are required 
to deliver SCPs to cancer survivors within a year of their treatment completion. Research 
demonstrates SCP delivery results in significant improvement in patient satisfaction, 
coordination of care, and survivorship care knowledge. In order to meet CoC standard 3.3 and 
bring understanding to SCPs function in cancer survivorship care a quality improvement project 
was initiated within an Arizona cancer center. SCPs were delivered at a survivorship visit to 
adult breast cancer patients. SCPs affect on survivors’ confidence in cancer self-care knowledge 
and care satisfaction was evaluated as well as the organization’s adherence to CoC standard 3.3 
requirements. Identified survivors were scheduled for a survivorship visit where a SCP was 
delivered by a oncology provider. Survivors perceived confidence in knowledge and satisfaction 
was measured using the modified 16-item Confidence in Survivorship Information Questionnaire 
(CSI). Questionnaires were completed pre and post survivorship visit. A paired t-test analysis 
was used to evaluate SCP effectiveness. There was an increase in the delivery of SCPs from zero 
to 57 with an 84 percent SCP delivery from August 2017 to January 2018. Survivors and 
providers verbalize value in SCPs. No statistical significance was found in the comparison of 
SCPs affect on survivors’ confidence in cancer self-care knowledge and care satisfaction to that 
of standard follow-up care; however, when comparing the pre/post questionnaire averages an 
improvement was noted across the board.The prospect of this project is to unveil the impact SCP 
delivery at a survivorship visit has on the selected metrics. This project aids as a director for 
organization wide implementation for CoC standard 3.3 requirement compliance.  
 
Keywords: survivorship, care plan, survivorship care plan, cancer, neoplasm, breast 
cancer, breast neoplasm, confidence, self-efficacy, satisfaction, health promotion, follow-
up recommendations, and follow-up adherence 
 
  
SURVIVORSHIP CARE PLANNING  3    
 
 
Survivorship Care Planning 
With medical advances in cancer treatment, detection, and supportive care the number of 
cancer survivors has exponentially grown (Rowland & Yancik, 2006). Of those diagnosed with 
cancer, two of three persons are expected to live at least five years past their diagnosis. 
Currently, 14 million cancer survivors live in the United States. By 2024 this number is expected 
to be more than 18 million (Centers for Disease Control and Prevention, 2016). 
Problem 
Reaching survivorship for cancer patients is a great triumph; however, the completion of 
treatment marks the beginning of another battle. Several challenges have been found in the realm 
of the continuation of post cancer treatment care. These challenges include the ambiguity of 
follow-up care and long-term effects and health risks due to cancer diagnosis and treatment 
which affect the physical, psychosocial, and emotional well-being of the survivor (Nolte et al., 
2016; Sprague et al., 2013). The uncertainty of follow-up care is due to oncologists’ inability to 
continue as the predominant provider in survivorship care with the increase of their patient 
population (Boeknout et al., 2014). This has placed survivorship care in the hands of primary 
care providers (PCPs), who along with survivors are uncertain of follow-up care for appropriate 
screening and surveillance (Jackson, Scheid, & Rolnick, 2013). This is due to the lack of care 
coordination during the transition phase from a cancer patient to a survivor (Salz & Baxi, 2016). 
Long-term physical, psychosocial, and emotional effects may include, but are not limited to: 
pain, fatigue, and psychological distress. Also, cancer survivors are at a higher risk of acquiring 
hypertension, diabetes, dyslipidemias, and becoming obese (Sisler, Chaput, Sussman, & 
Ozokwelu, 2016). If the survivor is unaware of these effects and risks it is difficult for them to 
optimize their own well-being and take the appropriate steps to prevent further health issues.  
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With the continuing evolution of the cancer survivor population it is important for 
survivors and providers to understand follow-up care and the unique physical, psychosocial, and 
emotional effects and risks of survivorship (DeSantis et al., 2014). Lack of understanding 
increases the survivors’ chances of acquiring and mismanaging long-term effects and chronic 
health issues. Also, the survivor may neglect cancer surveillance recommendations that identify 
cancer recurrence. Without proper survivorship care the survivor may not be able to make a 
successful transition from a patient to a survivor (Bulloch et al., 2017).  
Purpose and Rationale 
 In 2006, the Institute of Medicine (IOM) released the report From Cancer Patient to 
Cancer Survivor: Lost in Transition that brought attention to the inadequacies of current 
survivorship care. In an attempt to correct these inadequacies the IOM identified four essential 
components of survivorship care (a) prevention and detection of cancers (new or recurrent), (b) 
surveillance for cancer (spread, reassurance, or secondary), (c) interventions for long-term 
effects of cancer diagnosis and treatment, and (d) care coordination between providers in order to 
meet survivors specific needs (IOM & National Research Council [NRC], 2006). Alongside 
these essential survivorship components the IOM proposed 10 recommendations to help improve 
survivorship care, one of which stated that each cancer survivor should be given a SCP upon the 
completion of their primary treatment (Klemanski, Browning, & Kue, 2015). This SCP includes 
the survivors complete care summary (cancer diagnosis and treatment), possible long-term 
effects, surveillance and lifestyle recommendations, and provider identification in regard to who 
will be in charge of care (Bulloch et al., 2017). This specific recommendation has shown to be 
important among many key cancer stakeholders such as the American Society of Clinical 
Oncology (ASCO), American Cancer Society (ACS), National Comprehensive Cancer Network, 
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National Cancer Institute’s Office of Cancer Survivorship, National Coalition for Cancer 
Survivorship, Oncology Nursing Society, and LIVESTRONG. All have endorsed the IOM 
recommendation for SCPs (Klemanski, Browning, & Kue, 2016). The CoC has taken this 
recommendation a step further and is requiring that by 2018 at least 75 percent of cancer 
survivors must receive a SCP at the time of the survivor’s initial cancer treatment completion in 
order to be deemed a cancer center (Commission on Cancer, 2014). Despite key stakeholders 
efforts many health care systems and cancer centers have shown inconsistency with the 
implementation and deliverance of SCPs (Klemanski, Browning, & Kue, 2016). This paper 
investigates the use of SCPs through a current literature review, reviews the positive potential of 
SCPs, the challenges they present, and a review of the evidence surrounding them.  
Background and Significance  
The importance of SCPs has been unremittingly acknowledged in the cancer reform 
agenda for over a decade. However, despite organizational support, some evidence, and face 
validity, only a few cancer centers have implemented them within their practice routine (Nolte et 
al., 2016). Fifty-six percent of cancer programs in the United States admit to not using SCPs 
(Birken, Deal, Mayer, & Weiner, 2014). This has resulted in a lack of understanding as to how 
they impact both patients and providers in the transition of survivorship care (Nolte et al., 2016). 
Cancer survivors are uncertain as to what comes next in their transition from patient to survivor. 
Survivors are both fearful and uncertain about their survivorship. Although they are relieved to 
have completed treatment, they are unsure where this leaves them in relationship to their 
providers, and who is responsible for follow-up care and surveillance (Haq et al., 2013). 
Healthcare providers have conflicting perspectives on their roles in survivorship care, which is 
detrimental to the survivor as it may result in excess testing or worse, the omission of 
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recommended follow-up surveillance (Birken, Deal, Mayer, Weiner, 2014).  SCPs are meant to 
provide direction for survivors to improve health outcomes, clarify providers’ responsibilities, 
and decrease gaps in survivorship care (IOM & NRC, 2006). These care plans further encourage 
care coordination, communication between providers, improved survivorship care knowledge, 
and the understanding of needs that a survivor may have in their future (Forsythe et al., 2013). 
Survivors must be given information in order to be their own advocate. SCPs are intended to 
provide this information to improve patient advocacy (Keesing, McNamara, & Rosenwax, 2015).  
Although the amount of high-level evidence in the support of SCPs is limited, there have 
been several studies that have found benefits in the areas of survivor and provider satisfaction, 
improving knowledge related to the survivor’s diagnosis and treatment, and improved 
communication between the survivor and their providers (Nolte et al., 2016). Haq et al (2013) 
conducted a qualitative pilot study that found SCPs to effectively address survivorship follow-up 
needs. Faul et al. (2014) reported that SCPs improved survivorship care knowledge within older 
breast cancer survivors. Oancea & Cheruvu (2016) found that SCPs benefit survivor’s 
psychological well-being. Bulloch et al. (2015) noted that 100 percent of breast cancer survivors 
were interesting in getting a SCP. Two randomized control trials showed higher satisfaction rates 
in follow-up care for breast cancer survivors after receiving a SCP (Brennan, Gormally, Butow, 
Boyle, & Spillane, 2014). Blaauwbroek et al., (2012) found that adherence to follow-up 
recommendations was higher in survivors who provided their PCP with a SCP. Providers are 
shown to benefit from SCPs as well. Forsythe et al (2013) illustrated improved care coordination, 
communication, and confidence in providers’ knowledge of survivorship care post SCP receipt.  
In a multicenter trial participants were found to have improved satisfaction of care, survivorship 
knowledge, and care coordination after the implementation of a SCP (Palmer et al., 2015).  
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The current literature consistently calls for continued research. Barriers such as the 
implementation process, reimbursement, institutional resources, and time constraints need to be 
explored (Palmer et al., 2015). Tompkins and O’ Brien (2014) emphasized the importance of 
defining who is responsible for the coordination of survivors’ follow-up care through further 
research. Other authors focused on the facilitation, creation, and implementation process of SCPs 
(Forsythe et al., 2013). In a systematic review of qualitative studies, Keesing, McNamara, & 
Rosenwax (2015) found that although stakeholders agreed upon the importance of SCPs in 
survivorship care there is a lack of consensus on SCP format and deliverance, inconsistency of 
SCP reciprocation, and little high-level evidence to support the use of SCPs. Another area of 
research that was suggested is which key cancer survivor populations should be focused on. 
Forty percent of women cancer survivors are breast cancer survivors, it is recommended that 
future studies should be focused on breast and colon cancer survivors due to the fact that they 
make up most of the survivorship population to date (Salz & Baxi, 2016; Bulloch et al., 2015; 
Miller, 2008).  
 SCPs effect on survivors’ confidence in self-care and health promotion are other 
outcome metrics that require further research. Arora et al. (2011) reported 59 percent of 
survivors stated limited to no health promotion or prevention aspects were addressed in their 
follow-up care. Kvale et al. (2016) conducted a randomized control trial (RCT) and found that 
survivors who received SCPs reported higher self health and efficacy. This study illustrated the 
positive impact SCPs can have on survivors’ self-care and health promotion. Breast cancer 
survivors reported higher understanding of their follow-up care and self-efficacy after receiving a 
SCP compared to survivors who did not (Ezendam et al., 2014). Limited evidence exists in 
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relation to SCPs and survivors health benefits, therefore, more studies should aim to identify this 
relation (Mayer, Birken, Check, & Chen, 2015).  
Internal Evidence and PICO 
It has become evident to a cancer center in the metropolitan Phoenix area that there is 
much need and opportunity for an evidence-based practice project within the realm of cancer 
survivorship care. Currently, this cancer center is in the process of figuring out how to 
implement survivorship care plans within two pilot groups, the breast and colon cancer 
survivors. The process of implementation has not begun. This is an issue because of the looming 
CoC requirement. If they do not meet the CoC standard 3.3 requirements, as previously outlined 
in the purpose and rationale, they will no longer be deemed a cancer center. This illustrates the 
importance of survivorship care planning and the impact that is has on its stakeholders.  
This inquiry has lead to the clinically relevant PICO question, “In breast cancer 
survivors, how does a survivorship care plan compared to standard follow-up care affect 
survivors’ confidence in cancer self-care knowledge and care satisfaction?”  
Search Strategy 
An exhaustive search was conducted in order to answer this clinical inquiry. CINAHL 
(Appendix A), PubMed (Appendix B), and PsychINFO (Appendix C) were the three databases 
searched to retrieve valid, reliable, and applicable literature. Key search terms included: 
survivorship, care plan, care plans, or care planning, survivorship care plan, survivorship care 
plans, survivorship care planning, cancer survivorship, cancer, neoplasm, breast cancer, breast 
neoplasm, survivor, breast cancer survivor, confidence, self-efficacy, satisfaction, health 
promotion, follow-up recommendations, and follow-up adherence.  
SURVIVORSHIP CARE PLANNING  9    
 
 
CINAHL (Appendix A) was first searched using the Boolean connectors AND/OR. 
Survivorship care plans and breast cancer or breast neoplasm yielded 38 articles. Using the term 
cancer or neoplasm, which produced a yield of 44 articles, further expanded this search. The only 
limiting factor included in this initial search was a published date between 2013-2107. 
Additional searches were conducted for each outcome metric. The Boolean connector AND 
connected survivorship care plan or survivorship care plans to: cancer or neoplasm, breast cancer 
or breast neoplasm, survivor confidence, confidence, satisfaction, health promotion, follow-up 
recommendations, and follow-up adherence. Sixty-seven articles in total generated after these 
searches. No limitations, inclusion, or exclusion criteria were set on these searches due to the 
limited yield of articles.  
 A similar search was conducted in the PubMed database (Appendix B). Terms 
survivorship, care plan or care plans, and cancer or neoplasm were connected with the AND 
connector. The initial yield included 281 articles. This search was further limited to 81 articles 
by using the terms breast cancer or breast neoplasm instead of the general terms cancer or 
neoplasm. Including the term care planning within this same search yielded three additional 
articles. Outcome metrics were included within additional searches. Survivorship care plan or 
survivorship care plans were connected using the Boolean connector AND to cancer or 
neoplasm, breast cancer or breast neoplasm, confidence, satisfaction, health promotion, and 
follow-up recommendations. In total these searches yielded 137 articles. The limiter applied was 
that each term must be within the title or abstract of the article. 
 PsychINFO (Appendix C) was the final database searched. Initially 160 articles generated 
from the connected search terms of cancer survivorship and care plan or care planning. This 
search was condensed to 136 through the limiter of publication date from 2013-2017. Survivor or 
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breast cancer survivor was connected to previously searched terms through the AND connector. 
The limiter of publication date was removed. This search yielded 138 articles. In order to review 
articles that were specific to the clinical question’s population, breast cancer or breast neoplasm 
was connected to survivorship and care plan or care planning. Fifty-five articles were found to 
relate to this search.  
 Saturation was met based upon the reoccurrence of articles within each database. 
Between the three databases the final field was 259, however, many of these articles were 
duplicates, were not peer reviewed studies, and included childhood cancers, therefore they were 
discarded. Forty articles were further reviewed and appraised. Article exclusion continued if they 
were published prior to 2013, examined provider preference only, had limited generalizability 
due to modest sample diversity, had poorly structured descriptive and statistical data, and were 
irrelevant to the clinical inquiry. Eleven articles remained and were selected for further 
evaluation due to their quality and relevance to the clinical question (Appendix D).  
Critical Appraisal & Synthesis  
Eleven studies were retained after rapid critical appraisal. With regard to the level of 
evidence, four were level one (systematic reviews [SRs]), three were level two (randomized 
control trials [RCTs]), and four were level four: one cohort study, one feasibility study, and two 
cross-sectional studies (MeInyk & Fineout-Overholt, 2015). The majority of studies were 
conducted in the United States, and all were quantitative studies expect one. The quality of the 
chosen studies was deemed to be high after thorough review (Appendix D).  
Sample size among level II-IV evidence ranged from 79 to 1,615 participants. The 
studies’ demographic information revealed moderate homogeneity, which could result in bias of 
outcome data. No biases were specifically mentioned (Appendix D). All eleven studies involved 
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adult cancer survivors with a variable mean age ranging from 37 to 75 years. All studies had 
more female participants than male, and most participants were survivors of breast or colorectal 
cancer (Jefford et al, 2016). Four studies evaluated breast cancer survivors; one study evaluated 
colorectal cancer survivors, while the remaining studies evaluated a variation of breast, 
colorectal, gynecological, and other non-specified malignancies.  
 The primary intervention, implementation of SCPs, was evaluated across all studies. 
Three studies addressed SCPs along with treatment summaries (TS) as an intervention, while two 
studies addressed SCP plus a survivorship visit (SCPSV) as an intervention. Content and 
distribution of SCPs revealed heterogeneity. The outcomes of interest addressed across the 
studies included: quality of life, satisfaction, survivorship care knowledge, coordination of care, 
follow-up to recommended guideline adherence, survivor distress, and survivor self-efficacy 
(Appendix E). Self-efficacy and follow-up guideline adherence were the two variables that had 
the least representation, therefore, research efforts tat evaluate these variables are necessary  
(Appendix E). This information demonstrates value in the development of a project with the 
focus of improving survivorship care.  
There is heterogeneity of measurement tools. Most measurement tools were reported as 
being valid and reliable, however, it was difficult to assess because each study used distinct 
questionnaires and surveys. Potential for bias is apparent for the studies using surveys due to 
their subjective nature (MeInyk & Fineout-Overholt, 2015). Reliability and validity was 
demonstrated in all studies. (Appendix D).  
The overarching themes that were found, in relation to outcomes, were improved patient 
satisfaction and coordination of care. These outcomes were significantly demonstrated in five of 
the eleven appraised studies after SCP implementation. Another outcome that presented 
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significant improvement across multiple studies was survivorship care knowledge. The SCP 
intervention that included survivorship visits demonstrated the most significant outcome 
evidence (Appendix E).   
To date the results of SCP implementation have been inconclusive. It is unknown as to 
what factors are playing into these results. Despite this, there have been significant benefits in 
patient satisfaction, coordination of care, and survivorship care knowledge. Application of these 
significant findings in research and evidence-based practice projects could result in more 
significant data and SCP process improvement (Appendix D).  
Purpose Statement 
This evidence has lead to the initiation of an evidence-based quality improvement 
project. Breast cancer survivors that meet CoC survivor eligibility are the population of choice. 
This is based on evidence that breast cancer is the most prevalent cancer for those to survive and 
the most prominent cancer type. Through the involvement of stakeholders such as: the cancer 
center’s nursing research manager, nursing informatics, multidisciplinary oncology providers, 
the cancer registry, and the chosen SCP vendor team, data was collected to evaluate the cancer 
center’s compliance to CoC standard 3.3 requirements and breast cancer survivors’ confidence in 
cancer self-care knowledge and care satisfaction pre/post the initiation of a specific survivorship 
visit where a SCP was delivered. The prospect of this pilot project is to meet CoC standard 3.3 
requirements and bring understanding to SCPs function in cancer survivorship care. 
Models 
The Mayo Clinic Nursing Evidence-Based Practice Model (MCNEBP) was selected to 
guide the implementation of the proposed evidence-based SCP pilot intervention. This seven-
step model was developed to guide practice change within Mayo for the purpose of assuring the 
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use of best practice for attaining the best patient outcomes (Mayo Clinic, 2017). The MCNEBP 
Model is specific to the Mayo Clinic and its patients, therefore, appropriateness of setting and 
population is apparent. The seven steps include: formulate a question, search for evidence, 
appraise the evidence, compare and contrast, decision options, evaluate, and disseminate. An 
aspect unique to this model that is specific to SCP implementation is step five. There are four 
decision options to choose from after comparing and contrasting evidence. If strong evidence is 
in support of a change then the implementation of a practice change can occur, and if the 
evidence is inconclusive the options are to place the project on hold, implement a quality 
improvement project, or a research study (Mayo Clinic, 2017). Although the evidence for SCP 
implementation is inconclusive patient satisfaction, coordination of care, and cancer care 
knowledge elicited improvement; therefore, through the guidance of this model a project will be 
initiated using the significant data found for facility quality improvement. This model will 
further guide this project through evaluation and dissemination. SCPs effectiveness will be 
evaluated through a pre and post questionnaire, and findings will be disseminated through 
internal and external presentations. 
The Chronic Care Model (CCM) further guides SCP implementation within the cancer 
center. This model came about to correct the deficits that were present in the management of 
chronic disease. The goal of this model is to attain proactive disease management instead of 
reactive, which has resulted in improved care and patient outcomes (Improving Chronic Illness 
Care, 2017). In correlation to this project, the goal of SCPs is to improve the deficits that are 
present in cancer survivorship care; therefore, the CCM was adopted to guide the content and 
structure of SCP implementation. The six fundamental elements that make up this model 
includes: the community, the health system, self-management support, delivery system design, 
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decision support, and clinical information systems. Each element includes a change concept that 
is necessary for element improvement. These change concepts include: to meet patients’ needs 
through community resources, to create a health system that fosters safe and high quality care, 
patient empowerment and preparation in regards to their health and the care they should receive, 
effective and efficient care that supports self-management, promotion of care that is based off of 
evidence and patient preference, and readily assessable patient/population data to attain care that 
is efficient and effective. Evidence demonstrates that the products of combining these elements 
and their change concepts include healthier patients, satisfied providers, fiscal savings, improved 
patient-provider communication, improved patient participation in care, and enhanced utilization 
of provided resources in respect to chronic disease care (Wagner, 1998). The creation of a 
survivorship visit and the information that is included within the SCPs has been based upon these 
elements and change concepts. All elements and concepts have been incorporated into a 
personalized SCP. Breast cancer survivors will receive their SCP at a survivorship visit in the 
hope to improve their survivorship care from that of their current standard follow-up care. Using 
this model generates SCP component structure and connection, which in turn assists project 
development, implementation, and potential practice change.  
Methods 
An evidence-based quality improvement project was initiated within an accredited cancer 
center in Arizona. A SCP intervention was delivered at a survivorship visit to eligible adult 
breast cancer patients. The CoC’s survivor eligibility criteria included breast cancer patients 18 
and older that were treated with curative intent for an initial cancer occurrence. The CoC also 
required SCPs to be delivered within one year of patients’ cancer treatment completion. CoC 
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eligible breast cancer survivors included in the pilot were identified retrospectively by the 
organization’s cancer registry.  
Prior to the implementation of the intervention the organization’s breast cancer providers 
received SCP and project workflow education. This multi-disciplinary education was conducted 
for the purpose of optimizing the SCP delivery process. Starting in August 2017 identified 
survivors were scheduled for a survivorship visit. Prior to the visit SCPs were created by a 
registered nurse care coordinator and then reviewed and finalized by an oncology provider. The 
SCPs were reviewed and delivered by the oncology provider at a specified survivorship visit and 
included four essential elements: description of specific cancer diagnosis, treatments received, 
instruction for follow-up care, and health promotion recommendations. Survivors perceived 
confidence in cancer self-care knowledge and care satisfaction was measured using the 
Confidence in Survivorship Information Questionnaire (CSI). This 13-item questionnaire 
measures survivors’ confidence in their knowledge of cancer diagnosis, treatment, 
prevention/treatment of late disease/treatment effects, disease prevention, accessibility to 
resources, and family cancer risk (Palmer, Jacobs, Mao, & Stricker, 2012). With permission from 
the creators of the CSI three items were added to the questionnaire to address survivor care 
satisfaction. Although there is no known validity to date, the reliability of this instrument is set 
upon two subscales. The first three items of the questionnaire address survivor knowledge of 
their cancer diagnosis and treatment and have a Cronbach’s alpha of 0.77 (Palmer, Jacobs, Mao, 
& Stricker, 2012). The last 10 items have a Cronbach’s alpha of 0.95. This information 
demonstrates relevance to evaluation questions and reliability of the instrument. The CSI utilizes 
a three-point Likert scale with numerical values ranging from 1 (not at all confident) to 3 (very 
confident), whereas a 5-point Likert scale with numeric values ranging from 5 (very satisfied) 
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to 1 (very dissatisfied) was utilized for the evaluation of patient care satisfaction. Questionnaires 
were completed prior to receiving their SCP at the survivorship visit. Post CSI questionnaires 
were completed by phone in February 2018. The doctorate of nursing practice student contacted 
initial survey project participants by phone and followed an Institute of Review Board (IRB) 
script. A paired T-test analysis, alpha 0.5, was used to evaluate SCP effectiveness. Throughout 
the pilot the organization’s adherence to CoC standard 3.3 requirements was evaluated by 
tracking the number of survivors identified as needing a SCP, number of SCPs delivered, 
percentage of the two, and percentage of the correct SCP sent to health information 
management systems (HIMS) per provider.  
Project IRB approval was obtained by ensuring the protection of survivors’ privacy and 
rights through data being stored in encrypted servers/files, which were locked in cabinets. Also, a 
username and password protected encrypted access. All protected health information complied 
with HIPPA rules. The only individuals granted access to material were those who participated 
in the project or provided direct care to the patient. Data was stored for the duration of pilot 
project, and expires 24 months from project initiation. 
Results  
Data demonstrated an increase in the delivery of SCPs from zero to 57, and a practice 
change adherence (SCP delivery) of 84 percent from August 2017 to January 2018. Survivors 
and providers verbalize value in SCPs. Twenty-two breast cancer survivors completed a pre CSI 
questionnaire and 20 of those completed a post CSI questionnaire. No statistical significance was 
found in the comparison of SCPs effect on survivors’ confidence in cancer self-care knowledge 
and care satisfaction to that of standard follow-up care; however, when comparing the pre and 
post questionnaire averages an improvement was noted across the board. Survivors’ confidence 
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in their knowledge of: preventing and treating long-term physical effects, community resources 
available to them, family cancer risk, family risk information, and overall care satisfaction were 
the areas of most clinical significant improvement post survivorship visit and SCP delivery. For 
graphical representation of CSI questionnaire statistical and average findings reference appendix 
G and H.  
Discussion  
Throughout this project a team-based approach was utilized. The organization’s 
colorectal practice implemented SCPs through a workflow that was slightly different from 
breast’s. This team-based approach was shown useful through CSI questionnaire findings. An 
overall improvement in breast and colorectal cancer survivors' confidence in cancer self-care 
knowledge and care satisfaction was demonstrated, which is consistent with current literature 
and supports the continuation of SCP delivery. The colorectal practice identified significance in 
results unlike the breast practice. This was most likely due to their provider workflow 
consistency. Unfortunately provider inconsistency occurred in the breast practice due to an 
unexpected absence. This resulted in acquiring other providers who did not receive as extensive 
of education on SCP workflow and delivery as the original provider. This contributed to missed 
survivorship consults and delivery inconsistency due to a variation in eligible survivor 
identification. Organization compliance requires continued improvement to reach future SCP 
delivery recommendations; however, this project enhances current research findings in the fact 
that SCP effect is increased through consistency in provider education and the use of a focused 
survivorship visit. Project limitations included a small sample size and a six-month observation 
time. Another six months would have not only added to the sample size, but also allowed for the 
evaluation of SCP delivery effect on patient outcomes such as: National Comprehensive Cancer 
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Network follow-guideline adherence and health promotion behaviors (vaccine adherence and 
smoking cessation). The cost of the vended SCP product may be viewed as a burden by some, 
however, the reduction in cost of care through improvements in survivors’ self-efficacy and 
disease prevention and health promotion practices may decrease the use of unnecessary 
healthcare resources. With this outcome vended SCP products may be viewed as a cost saving. 
Future research should include larger sample sizes and further investigation to identify the best 
SCP tool and delivery process.  
Conclusion 
SCP delivery through a strategically designed survivorship visit shows to be an 
operational framework that improves the transition from cancer patient to survivor. This project 
aids as a guide for organization SCP implementation and CoC standard 3.3 requirement 
compliance. The implementation of SCPs at a survivorship visit not only serves as a device to 
instill greater confidence in survivors’ cancer self-care knowledge, but also improves survivors’ 
overall care satisfaction. In the end, effectively empowering cancer survivors in their 
survivorship transition has the potential to improve their chances for long-term survival and 
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Mayer, D. K. 
(2015). Summing it 
up: an integrative 
review of studies of 
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Funding: The 




























Categories of Focus: 








Inclusion Criteria:  
results of empirical 
study, CS diagnosed at 
>/= 18 y/o, relate to 
cancer and report 
findings that associated 
with SCPs 
Exclusion Criteria:  
IV: SCP 
 
DV 1: SCP content  
DV 2: SCP  
dissemination and 
implementation 
DV3: survivor and 








survey tools  
 PRISMA Discrepancy 
between HC 
providers/survivors 









Lack of info. on 
delivery preference 
Few studies found 
patients preferred 
delivery right before 
or directly after 
treatment.  
 
Only 12.5% of 
patients received 
SCP (10 cancer 
LOE: I 
 
Strength: evaluation of a 
vast amount of evidence. 
Both provider and 
survivor perspectives 
evaluated.   
 
Limitations: 4 high level 
studies availability. 
Limited generalizability 
(lack of diversity).  
Weak testing of data 
measurement tools   
 





research to address SCP 
methodology, content , 
and outcomes.   
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abstracts or 
presentations,  adult 








Oancea, S. C. 
(2016). 
Psychological 



























recipient of SCP 
and 
psychological 
distress in adult 
cancer survivors 
post treatment.  
N= 3,191 
 
G1: CS 1-5 y from 
diagnosis 
N:1046 




Received FCI: n:789 
Received TS: n:366 
 
G2: CS >5 y from 
diagnosis 
N:2145 







CD or more: n=690 
Received SCI: n=1424 
IV 1: TS only 
IV: FCI only 
IV: TS + FCI  
IV 4: non TS or FCI 
 

































3x higher if only 
FCI receipt, as 
compared to FCI + 






was 2x higher only 
FCI receipt (AOR= 




Strengths: sample size, 
first study to look at 




TS, but no FCI group. 
Pain severity/comorbid 
conditions not controlled 
or assessed. Questions 
subject to recall; 
potential bias  
 
Applicability: SCPs has 
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Received TS; n=611 
 
Setting: Telephone 




Cancer diagnosis at 
>/=18 y/o, not pregnant 
at time of study, >1 










Palmer, S. C. 
(2015). Outcomes 
and satisfaction 
after delivery of a 
breast cancer 
survivorship care 
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provided disclosure, 






















SCP to BC 




Mean MFD: 3.43 
Stage at diagnosis:  
Stage 0: n=10 
Stage 1: n=52 
Stage 2 n=51 






Mean SF-12 mental 
health score: 54.38 
(sd:11.19) 
Mean SF-12 physical 




Seven NCI designated 
comprehensive cancer 
IV1: Care prior to 
SCP 
IV2: SCP delivery 
 





























tool not stated)  
Weak 












IV2: SCP use: 64% 
for decision to 
exercise, 62% for 
dietary changes, and 
62% for directing 
















characteristics,  cancer 








population, tools (self 





standardization across an 
array of settings. Useful 
in new BC survivors.  
 
Feasibility:  
Success at all sites 
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centers and their 
community practices.  
 
Inclusion criteria:  >/= 
18 y/o, diagnosis and 
treatment of primary 
BC or DCI, completion 
of cancer therapy, and 
scheduled survivorship 
visit  at SCOEN 
 
Exclusion criteria:  
unable to complete 
inform consent d/t 
barriers,  and previous 







and logistical support 
SCPs can be effectively 
delivered   
 
































































Year 2015 2014 2015 2016 2015 2016 2016 2016 2015 2016 2015 
LOE II I VI II I VI I II I VI II 
Design RCT SR FS RCT SR CS SR RCT SR CS PCS 
Length 24m N/A 2m 6m N/A 1d N/A 3m N/A 1d 3m 
SCP X X X  X X X  X X X 
SCPSV    X    X    
TS      X X   X  
QOL NS   NS   NS     
S NS           
SCK            
COC NS       NS    
FUGRA NS           
SD NS NS  NS   NS     
HPB            
SE            
 
CS: cross-sectional study, COC: coordination of care, FS: feasibility study, FUGRA: follow-up 
guideline recommendation adherence, HPB: health promotion behaviors, LOE: level of evidence, NS: 
not significant, PC: perspective cohort study, QOL: quality of life, RCT: randomized control trial, S: 
satisfaction, SCK: survivorship care knowledge, SCP: survivorship care plan, SCPSV: survivorship 
care plan survivorship visit, SD: survivor distress, SE: self-efficacy, SR: systematic review, TS: 
treatment summary 
 




Evidence-Based Practice Model  
 










CSI Questionnaire Analysis 
 
Paired Samples Test 
 
Paired Differences 
t df Sig. (2-tailed) 
95% Confidence 
Interval of the 
Difference 
Upper 
Pair 1 Type - Type2 .333 .370 19 .716 
Pair 2 Stage - Stage2 .215 .000 19 1.000 
Pair 4 Prevent - Prevent2 .159 -.809 19 .428 
Pair 5 Physical Effects  - Physical 
Effects2 
.263 .000 19 1.000 
Pair 6 Prevent Physical Effects - 
Prevent Physical Effects2 
.007 -2.042 19 .055 
Pair 7 Treat Physical Effects - Treat 
Physical Effects2 
.088 -1.453 19 .163 
Pair 8 Emotional Effects - Emotional 
Effects2 
.215 .000 19 1.000 
Pair 9 Prevent Emotional Effects - 
Prevent Emotional Effects2 
.189 -.438 19 .666 
Pair 10 Treat Emotional Effects - Treat 
Emotional Effects2 
.200 -.438 18 .667 
Pair 11 Community Resources - 
Community Resources2 
.260 -.767 19 .453 
Pair 12 Family  Risk - Family  Risk2 .133 -1.287 18 .215 
Pair 13 Family  information - Family  
information2 
.202 -1.073 18 .297 
Pair 14 Survivorship care - Survivorship 
care2 
.379 -.644 17 .528 
Pair 15 Wellness - Wellness2 .349 -1.031 17 .317 
Pair 16 Health Promotion - Health 
Promotion2 


















Type Stage Treatments Prevent























Confidence in Long-term Effects
Series1 Series2
















Community Resources Family  Risk Family  information







Survivorship care Wellness Health Promotion
Satisfaction
Series1 Series2
